Advanced Enzyme, a company in the Biotechnology industry, reported revenue of ₹215 crore and net profit of ₹51 crore for the September 2026 quarter.
Advanced Enzyme (NSE: ADVENZYMES) closed at ₹290.45 on 20 Nov 2026, down 10.7% over the past year. Its market capitalisation is ₹3,182 crore and it trades at 19.6 times earnings.
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.